A medication used to treat mild to moderate ulcerative colitis by gradually releasing an anti-inflammatory agent in the intestines, helping to maintain remission.

Indications:
- Treatment of mild to moderate ulcerative colitis attacks.
- Maintenance of remission in patients with ulcerative colitis.
- Reduction of intestinal inflammation and relief of related symptoms such as abdominal pain, diarrhea, and rectal bleeding.

Active Ingredient:
- Mesalazine 2g per sachet.


Precautions:
- Do not use if allergic to mesalazine or other salicylates.
- Consult your doctor if you have severe liver or kidney disease, asthma, a peptic ulcer, or a condition that increases bleeding risk.
- Take care to maintain adequate hydration to reduce the risk of kidney stones.
- Monitor for serious skin reactions, blood disorders, myocarditis, pericarditis, or increased intracranial pressure.
- Inform your doctor of all other medications being taken.
- Pregnancy and breastfeeding: consult your doctor before use.
- Seek immediate medical attention in case of overdose or severe side effects.

Side Effects:
- Diarrhea.
- Abdominal Pain.
- Nausea.
- Vomiting.
- Abdominal Pain.
- Headache.
- Rash.
- Myocarditis.
- Pericarditis.
- Pancreatitis.
- Dizziness.
- Photosensitivity.
- Anemia.
- Liver Disorders.
- Kidney Disorders.
- Peripheral Neuropathy.
- Severe Skin Reactions.
- Hair Loss.
- Muscle Pain.
- Joint Pain.
- Allergic Reactions.


Drug-Drug Interactions:
- Azathioprine, 6-mercaptopurine, or thioguanine.
- Anticoagulants such as warfarin.
- Non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin.